4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000007
Chief Operating Officer sold 28,336 shares at an average $15.05 ($426,383)
- Chief Operating Officer acquired 22,376 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shea Jacqueline Elizabeth · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +22,376 | $3.62 | $81,001 | 66,871 | D |
| 2021-02-01 | Sale : show line 2 in the form | −22,376 | $15.06 | $336,983 | 44,495 | D |
| 2021-02-01 | Sale : show line 3 in the form | −5,960 | $15.00 | $89,400 | 38,535 | D |
| Open-market sales · 28,336 sh · avg $15.05 · $426,383 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 4 in the form Common Stock Option | −22,376 | 100,000 | D |
Loading xslF345X03/wf-form4_161239754472771.xml…